AR039596A1 - USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION - Google Patents
USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTIONInfo
- Publication number
- AR039596A1 AR039596A1 ARP030100770A AR039596A1 AR 039596 A1 AR039596 A1 AR 039596A1 AR P030100770 A ARP030100770 A AR P030100770A AR 039596 A1 AR039596 A1 AR 039596A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- nz1z2
- alkyl
- hydrogen
- treatment
- Prior art date
Links
Abstract
Benzimidazoles para el tratamiento de la disfunción sexual y composiciones que contienen compuestos de fórmula (1) para el tratamiento de la disfunción sexual. Reivindicación 1: Uso de un compuesto de fórmula (1), una sal aceptable para uso farmacéutico, éster, amida o profármaco del mismo, donde; A se selecciona de entre el grupo de fórmulas (2); X se selecciona entre el grupo formado por NH, O y S; L se seleccionan entre el grupo formado por CH2, CH2CH2, CH2CH2CH2 y CH2CH2CH2CH2; R1, R2, R3, R4 y R5 se selecciona cada uno independientemente entre el grupo formado por hidrógeno, alcoxi, alquenilo, alquilo, alquilsulfinilo, alquilsulfonilo, alquiltio, alquinilo, alcoxicarbonilo, alquilcarbonilo, alquilcarboniloxi, carboxi, ciano, formilo, halógeno, haloalcoxi, haloalquilo, hidroxi, hidroxialquilo, mercapto, nitro, -NZ1Z2, (NZ1Z2)carbonilo y (NZ1Z2)sulfonilo donde Z1 y Z2 se seleccionan cada uno independientemente entre el grupo formado por hidrógeno, alquilo, alquilcarbonilo, alquilsulfonilo y formilo; RA, RB, RC y RD se seleccionan cada uno independientemente entre el grupo formado por hidrógeno, alcoxi, alquenilo, alquilo, alquilsulfinilo, alquilsulfonilo, alquiltio, alquinilo, alcoxicarbonilo, alquilcarbonilo, alquilcarboniloxi, carboxi, ciano, formilo, halógeno, haloalcoxi, haloalquilo, hidroxi, hidroxialquilo, mercapto, nitro, -NZ1Z2 y (NZ1Z2)carbonilo; RE se selecciona entre el grupo formado por hidrógeno, alcoxicarbonilo, alquilo, alquilcarbonilo, arilcarbonilo, cicloalquilcarbonilo, heterociclocarbonilo y (NZ1Z2)carbonilo; RF se selecciona entre el grupo formado por hidrógeno y alquilo; Z se selecciona entre el grupo formado por N, C y CH; y --- es un enlace cuando Z es C y --- está ausente cuando Z es N o CH, caracterizado porque es para la fabricación de un medicamento para el tratamiento de la disfunción sexual en un mamífero.Benzimidazoles for the treatment of sexual dysfunction and compositions containing compounds of formula (1) for the treatment of sexual dysfunction. Claim 1: Use of a compound of formula (1), a salt acceptable for pharmaceutical, ester, amide or prodrug use thereof, wherein; A is selected from the group of formulas (2); X is selected from the group consisting of NH, O and S; L are selected from the group consisting of CH2, CH2CH2, CH2CH2CH2 and CH2CH2CH2CH2; R1, R2, R3, R4 and R5 are each independently selected from the group consisting of hydrogen, alkoxy, alkenyl, alkyl, alkylsulfinyl, alkylsulfonyl, alkylthio, alkynyl, alkoxycarbonyl, alkylcarbonyl, alkylcarbonyloxy, carboxy, cyano, formyl, halogen, haloalkoxy , haloalkyl, hydroxy, hydroxyalkyl, mercapto, nitro, -NZ1Z2, (NZ1Z2) carbonyl and (NZ1Z2) sulfonyl where Z1 and Z2 are each independently selected from the group consisting of hydrogen, alkyl, alkylcarbonyl, alkylsulfonyl and formyl; RA, RB, RC and RD are each independently selected from the group consisting of hydrogen, alkoxy, alkenyl, alkyl, alkylsulfinyl, alkylsulfonyl, alkylthio, alkynyl, alkoxycarbonyl, alkylcarbonyl, alkylcarbonyloxy, carboxy, cyano, formyl, halogen, haloalkoxy, haloalkyl , hydroxy, hydroxyalkyl, mercapto, nitro, -NZ1Z2 and (NZ1Z2) carbonyl; RE is selected from the group consisting of hydrogen, alkoxycarbonyl, alkyl, alkylcarbonyl, arylcarbonyl, cycloalkylcarbonyl, heterocyclocarbonyl and (NZ1Z2) carbonyl; RF is selected from the group consisting of hydrogen and alkyl; Z is selected from the group consisting of N, C and CH; and --- is a link when Z is C and --- is absent when Z is N or CH, characterized in that it is for the manufacture of a medicament for the treatment of sexual dysfunction in a mammal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/094,265 US7022728B2 (en) | 2001-03-09 | 2002-03-08 | Benzimidazoles that are useful in treating male sexual dysfunction |
| US10/236,812 US6960589B2 (en) | 2001-03-09 | 2002-09-06 | Benzimidazoles that are useful in treating sexual dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039596A1 true AR039596A1 (en) | 2005-03-02 |
Family
ID=38812748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100770 AR039596A1 (en) | 2002-03-08 | 2003-03-06 | USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR039596A1 (en) |
| MY (1) | MY139582A (en) |
| PE (1) | PE20040206A1 (en) |
| UY (1) | UY27706A1 (en) |
-
2003
- 2003-03-06 MY MYPI20030789 patent/MY139582A/en unknown
- 2003-03-06 AR ARP030100770 patent/AR039596A1/en not_active Application Discontinuation
- 2003-03-07 PE PE2003000229A patent/PE20040206A1/en not_active Application Discontinuation
- 2003-03-07 UY UY27706A patent/UY27706A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY139582A (en) | 2009-10-30 |
| UY27706A1 (en) | 2003-10-31 |
| PE20040206A1 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR035783A1 (en) | COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE IN THE MANUFACTURE OF MEDICINES TO MODULATE EFFECTS OF HISTAMINE RECEPTORS 3 | |
| ES2531256T3 (en) | Fungicidal amides | |
| PE20081448A1 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| PE20011166A1 (en) | PYRIDINES, PYRIMIDINES, PURINONES, PYRROLOPYRIMIDINONES AND PYRROLOPYRIDINONES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR | |
| AR040076A1 (en) | DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA | |
| PE20220931A1 (en) | PYRAZOLO[3,4-B]PYRAZINE-TYPE SHP2 PHOSPHATASE INHIBITORS | |
| CO5690551A2 (en) | TETRAZOL DERIVATIVES AND METHODS FOR TREATMENT WITH THE SAME DISORDERS RELATED TO METABOLISM | |
| CO5550421A2 (en) | INDOL DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASE | |
| PE20071286A1 (en) | COMPOSITION TO INDUCE VIRAL TOLERANCE IN PLANTS | |
| PE20060691A1 (en) | SERINAMIDES REPLACED BY BENZOYL | |
| AR063022A1 (en) | INDOL DERIVATIVES ANTAGONISTS OF THE GLUCAGON RECEIVER, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES TO TREAT MELLITUS TYPE 2 DIABETES AND RELATED PATHOLOGICAL STATES. | |
| CO6220931A2 (en) | SERINE PROTEASE INHIBITORS FOR THE TREATMENT OF HCV INFECTIONS | |
| AR072952A1 (en) | 2-IMINO-3-METHYL-PIRROLOPIRIMIDINONA PHENYL-REPLACED COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS AND THEIR USE | |
| PE20030702A1 (en) | PDE9 INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS | |
| PE20050767A1 (en) | AMINO-BENZAZOLES AS INHIBITORS OF THE P2Y1 RECEPTOR | |
| AR034448A1 (en) | USE OF NUCLEOSID DERIVATIVES, SUCH DERIVATIVES OF NUCLEOSIDS FOR SUCH USE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND USE OF SUCH COMPOSITIONS | |
| AR054799A1 (en) | OXINDOL DERIVATIVES | |
| PE20060555A1 (en) | PIRROL-OXINDOL DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | |
| AR048641A1 (en) | ARTH- OR HETEROARILAMIDE ORTHOSUSTITUTED COMPOUNDS USEFUL AS ANTAGO-NISTAS OF THE PROSTAGLANDINAS E2 RECEIVER; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICAME | |
| BRPI0608732A2 (en) | compound or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof, salt of a compound, process for preparing a compound, use of a compound, pharmaceutical composition, and | |
| AR054083A1 (en) | IMIDAZOL COMPOUNDS AND ITS USE TO PREPARE MEDICATIONS | |
| AR066348A1 (en) | IAP INHIBITORS | |
| AR062965A1 (en) | MODULATING COMPOUNDS OF MGLUR5 GLUTAMATOMETABOTROPIC RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THERAPEUTIC USES IN ACUTE AND CHRONIC GASTROINTESTINAL, NEUROLOGICAL AND PSYCHIATRIC DISORDERS | |
| AR053554A1 (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | |
| AR049711A1 (en) | HETEROCICLIC COMPOUNDS CONDENSED AS INHIBITORS OF ALDOSTERONE SINTASA; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF DISEASES RELATED TO HYPERALDOSTERISM AND EXCESSIVE CORTISO RELEASE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |